Your browser doesn't support javascript.
loading
Absence of PD-L1 on tumor cells is associated with reduced MHC I expression and PD-L1 expression increases in recurrent serous ovarian cancer.
Aust, Stefanie; Felix, Sophie; Auer, Katharina; Bachmayr-Heyda, Anna; Kenner, Lukas; Dekan, Sabine; Meier, Samuel M; Gerner, Christopher; Grimm, Christoph; Pils, Dietmar.
Afiliação
  • Aust S; Dept. of Obstetrics and Gynecology, Comprehensive Cancer Center (CCC), Medical University of Vienna, Vienna, Austria.
  • Felix S; Dept. of Obstetrics and Gynecology, Comprehensive Cancer Center (CCC), Medical University of Vienna, Vienna, Austria.
  • Auer K; Dept. of Obstetrics and Gynecology, Comprehensive Cancer Center (CCC), Medical University of Vienna, Vienna, Austria.
  • Bachmayr-Heyda A; Dept. of Obstetrics and Gynecology, Comprehensive Cancer Center (CCC), Medical University of Vienna, Vienna, Austria.
  • Kenner L; Dept. of Pathology, Medical University of Vienna, Vienna, Austria.
  • Dekan S; Dept. of Pathology, Medical University of Vienna, Vienna, Austria.
  • Meier SM; Dept. of Analytical Chemistry, University of Vienna, Vienna, Austria.
  • Gerner C; Dept. of Analytical Chemistry, University of Vienna, Vienna, Austria.
  • Grimm C; Dept. of Obstetrics and Gynecology, Comprehensive Cancer Center (CCC), Medical University of Vienna, Vienna, Austria.
  • Pils D; Section for Clinical Biometrics, Center for Medical Statistics, Informatics, and Intelligent Systems (CeMSIIS), Medical University of Vienna, Vienna, Austria.
Sci Rep ; 7: 42929, 2017 03 07.
Article em En | MEDLINE | ID: mdl-28266500

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antígenos de Histocompatibilidade Classe I / Receptor de Morte Celular Programada 1 Tipo de estudo: Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antígenos de Histocompatibilidade Classe I / Receptor de Morte Celular Programada 1 Tipo de estudo: Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Áustria